share_log

金斯瑞生物科技：建議修訂現行組織章程大綱及章程細則及採納經修訂的組織章程大綱及章程細則

GENSCRIPT BIO: PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES AND ADOPTION OF THE AMENDED MEMORANDUM AND ARTICLES

香港交易所 ·  Apr 12 07:01
Summary by Moomoo AI
金斯瑞生物科技股份有限公司（「金斯瑞生物科技」）於2024年4月12日宣布，公司董事會提出修訂現行組織章程大綱及章程細則，以符合最新的監管要求及內部管理目的。修訂內容包括擴大無紙化上市機制、通過電子方式傳播公司通訊，以及更新以配合2023年12月31日起生效的上市規則。該修訂需經股東於即將召開的股東周年大會上以特別決議案方式批准後方可生效。公司將適時向股東寄發包含修訂詳情的通函、股東周年大會通告及委任表格。
金斯瑞生物科技股份有限公司（「金斯瑞生物科技」）於2024年4月12日宣布，公司董事會提出修訂現行組織章程大綱及章程細則，以符合最新的監管要求及內部管理目的。修訂內容包括擴大無紙化上市機制、通過電子方式傳播公司通訊，以及更新以配合2023年12月31日起生效的上市規則。該修訂需經股東於即將召開的股東周年大會上以特別決議案方式批准後方可生效。公司將適時向股東寄發包含修訂詳情的通函、股東周年大會通告及委任表格。
Kingsway Biotechnology Co., Ltd. (“Kingsley Biotechnology”) announced on 12 April 2024 that the Company's Board of Directors has proposed amendments to the current Articles of Association and Articles of Association to meet the latest regulatory requirements and internal management purposes. THE AMENDMENTS INCLUDE THE EXPANSION OF PAPERLESS LISTING MECHANISMS, THE TRANSMISSION OF COMPANY COMMUNICATIONS ELECTRONICALLY, AND UPDATES TO THE LISTING RULES EFFECTIVE FROM 31 DECEMBER 2023. The amendment is subject to approval by a special resolution at the upcoming Annual General Meeting of Shareholders. The Company will send to shareholders a circular containing the amendment details, the Notice of the Annual General Meeting and the Nomination Form in due course.
Kingsway Biotechnology Co., Ltd. (“Kingsley Biotechnology”) announced on 12 April 2024 that the Company's Board of Directors has proposed amendments to the current Articles of Association and Articles of Association to meet the latest regulatory requirements and internal management purposes. THE AMENDMENTS INCLUDE THE EXPANSION OF PAPERLESS LISTING MECHANISMS, THE TRANSMISSION OF COMPANY COMMUNICATIONS ELECTRONICALLY, AND UPDATES TO THE LISTING RULES EFFECTIVE FROM 31 DECEMBER 2023. The amendment is subject to approval by a special resolution at the upcoming Annual General Meeting of Shareholders. The Company will send to shareholders a circular containing the amendment details, the Notice of the Annual General Meeting and the Nomination Form in due course.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more